Close Menu

Ohio State

The trial combines clinical NGS panels with research-based exome and transcriptome sequencing.

The paper describes a method of identifying genetic markers for reconstructing the phylogeny of the Penstemon genus from low coverage WGS data.

Affymetrix has been awarded

NEW YORK (GenomeWeb) – The Antarctic midge genome appears to have jettisoned a slew of sequences from its genome during adaptation to its extreme environment, but has managed to avoid dramatic reductions in its protein-coding gene set, according to a new Nature Communications

Using a genomic strategy, researchers led by Ohio State University's David Carbone have identified a rare genetic mutation that they believe might characterize a small sub-group of lung cancer patients who could be super-responders to the cancer drug Nexavar (sorafenib).

NEW YORK (GenomeWeb News) – Life Technologies has added 11 new members from the US and Canada to its Ion AmpliSeq Exome Certified Service Provider program, the company said today.

NEW YORK (GenomeWeb News) – Ohio State University today announced it has licensed to Microlin Bio almost 100 issued and pending microRNA patents for the potential development of cancer diagnostics and treatments.

Using data from The Cancer Genome Altlas' comprehensive analysis of breast cancer, researchers from the University of Ferrara and Ohio State University have developed a 37-marker combined microRNA and mRNA signature that shows promise as a prognostic tool for patients with early

While microRNAs have already been established as key players in a host of regulatory and developmental processes, a new study from researchers at Ohio State University has linked a single one of these small, non-coding RNAs to proper embryonic tissue segmentation.

The US Department of Health and Human Services last month disclosed that Ohio State University researcher Terry Elton was found guilty of scientific misconduct related to his work on microRNAs in cardiac developmental and pathological processes.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.